Literature DB >> 13847673

The nature and rates of excretion of radioactive breakdown products of I131-albumin in the rabbit.

F ZIZZA, T J CAMPBELL, E B REEVE.   

Abstract

When I(131)-albumin is given intravenously to rabbits, the radioactive breakdown products that are released into the plasma and urine can be extracted into acetone. Paper chromatography and paper electrophoresis show that about 80 per cent of these are I(131)-iodide and the remainder are organic I(131)-iodine compounds. When I(131)-iodide is given to rabbits taking iodide in their drinking water, the radioactivity is quantitatively excreted, without being accumulated in the tissues and without becoming attached to the plasma proteins. The rate of excretion can be defined by a first order rate process with a rate constant, a, ranging between 1 and 3day(-1). The organic I(131)-iodine compounds liberated during the metabolism of I(131)-albumin can be closely matched by a mixture of the organic I(131)-iodine compounds liberated during the metabolism of I(131)-monoiodotyrosine, I(131)-diiodotyrosine, and the amino acids released by digestion from I(131)-albumin. These organic I(131)-iodine compounds are not accumulated in the body and their radioactivity does not become attached to the plasma proteins. Their radioactivity is excreted as fast or faster than that of I(131)-iodide, and, to a satisfactory approximation, the same equations describing the excretion of I(131)-iodide with the same constants may be used for describing the excretion of the organic I(131)-iodine. These results permit improved estimates of the distribution and catabolism of I(131)-albumin.

Entities:  

Keywords:  IODINE/radioactive; SERUM ALBUMIN/metabolism

Mesh:

Substances:

Year:  1959        PMID: 13847673      PMCID: PMC2194982          DOI: 10.1085/jgp.43.2.397

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  12 in total

1.  The fractionation of urinary iodine. 2. Metabolites excreted during treatment of carcinoma of the thyroid.

Authors:  K FLETCHER
Journal:  Biochem J       Date:  1957-09       Impact factor: 3.857

2.  The metabolism of iodotyrosines. I. The fate of mono- and di-iodotyrosine in normal subjects and in patients with various diseases.

Authors:  J B STANBURY; A A KASSENAAR; J W MEIJER
Journal:  J Clin Endocrinol Metab       Date:  1956-06       Impact factor: 5.958

3.  Mechanism of protein turnover studied with cystine-S35, lysine-C14 doubly labeled plasma proteins of the dog.

Authors:  P D GOLDSWORTHY; W VOLWILER
Journal:  J Biol Chem       Date:  1958-02       Impact factor: 5.157

4.  Site of catabolism of serum albumin.

Authors:  D GITLIN; J R KLINENBERG; W L HUGHES
Journal:  Nature       Date:  1958-04-12       Impact factor: 49.962

5.  [Nature of the products eliminated in the urine after administration of diiodo-L-tyrosine].

Authors:  J ROCHE; R MICHEL; J CLOSON; O MICHEL
Journal:  Rev Fr Etud Clin Biol       Date:  1958-02

6.  Interrelations in amino acid and carbohydrate metabolism; studies of the nitrogen sparing action of carbohydrate with the isolated perfused rat liver.

Authors:  L L MILLER; W T BURKE; D E HAFT
Journal:  Fed Proc       Date:  1955-09

7.  Distribution and elimination of 131 I- and 14C-labelled plasma proteins in the rabbit.

Authors:  S COHEN; R C HOLLOWAY; C MATTHEWS; A S MCFARLANE
Journal:  Biochem J       Date:  1956-01       Impact factor: 3.857

8.  Quantitative aspects of iodine metabolism in man.

Authors:  D S RIGGS
Journal:  Pharmacol Rev       Date:  1952-09       Impact factor: 25.468

9.  The isolation of iodinated amino acids from thyroid tissue by means of starch column chromatography.

Authors:  B M DOBYNS; S R BARRY
Journal:  J Biol Chem       Date:  1953-09       Impact factor: 5.157

10.  Chromatographic analysis of radioactive iodine compounds from the thyroid gland and body fluids.

Authors:  J ROCHE; S LISSITZKY; R MICHEL
Journal:  Methods Biochem Anal       Date:  1954
View more
  11 in total

1.  PASSAGE OF TRANSFERRIN, ALBUMIN AND GAMMA GLOBULIN FROM MATERNAL PLASMA TO FOETUS IN THE RAT AND RABBIT.

Authors:  E H MORGAN
Journal:  J Physiol       Date:  1964-05       Impact factor: 5.182

2.  THE METABOLISM OF GAMMA GLOBULINS IN MYELOMA AND ALLIED CONDITIONS.

Authors:  C A ALPER; T FREEMAN; J WALDENSTROEM
Journal:  J Clin Invest       Date:  1963-12       Impact factor: 14.808

3.  METABOLISM OF BENCE JONES PROTEINS.

Authors:  A SOLOMON; T A WALDMANN; J L FAHEY; A S MCFARLANE
Journal:  J Clin Invest       Date:  1964-01       Impact factor: 14.808

4.  Studies on albumin synthesis: the effects of dextran and cortisone on albumin metabolism in rabbits studied with albumin-I-131.

Authors:  M A ROTHSCHILD; M ORATZ; E WIMER; S S SCHREIBER
Journal:  J Clin Invest       Date:  1961-03       Impact factor: 14.808

5.  The effect of hypergammaglobulinemia on albumin metabolism in hyperimmunized rabbits studied with albumin-I-131.

Authors:  M A ROTHSCHILD; S S SCHREIBER
Journal:  J Clin Invest       Date:  1962-07       Impact factor: 14.808

6.  In vivo behavior of radioiodinated rabbit antithrombin III. Demonstration of a noncirculating vascular compartment.

Authors:  T H Carlson; A C Atencio; T L Simon
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

7.  Metabolism of plasminogen in healthy subjects: effect of tranexamic acid.

Authors:  D Collen; G Tytgat; H Claeys; M Verstraete; P Wallén
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

8.  Calculation of the albumin catabolic rate in the non-steady state.

Authors:  J J FRANKS
Journal:  J Gen Physiol       Date:  1963-01       Impact factor: 4.086

9.  The role of the gut in albumin catabolism. II. Studies in enterectomized rabbits.

Authors:  J J FRANKS; K W EDWARDS; W W LACKEY; J B FITZGERALD
Journal:  J Gen Physiol       Date:  1963-01       Impact factor: 4.086

10.  The kinetics of the distribution and breakdown of 1131-albumin in the rabbit. Observations on several mathematical descriptions.

Authors:  E B REEVE; J E ROBERTS
Journal:  J Gen Physiol       Date:  1959-11       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.